127 related articles for article (PubMed ID: 8872971)
1. Deficient IgA1 immune response to nasal cholera toxin subunit B in primary IgA nephropathy.
de Fijter JW; Eijgenraam JW; Braam CA; Holmgren J; Daha MR; van Es LA; van den Wall Bake AW
Kidney Int; 1996 Sep; 50(3):952-61. PubMed ID: 8872971
[TBL] [Abstract][Full Text] [Related]
2. Decreased IgA1 response after primary oral immunization with live typhoid vaccine in primary IgA nephropathy.
Roodnat JI; de Fijter JW; van Kooten C; Daha MR; van Es LA
Nephrol Dial Transplant; 1999 Feb; 14(2):353-9. PubMed ID: 10069188
[TBL] [Abstract][Full Text] [Related]
3. Secretory immunoglobulin A (IgA) responses in IgA nephropathy patients after mucosal immunization, as part of a polymeric IgA response.
Eijgenraam JW; Oortwijn BD; Kamerling SW; de Fijter JW; van den Wall Bake AW; Daha MR; van Kooten C
Clin Exp Immunol; 2008 May; 152(2):227-32. PubMed ID: 18336594
[TBL] [Abstract][Full Text] [Related]
4. Immune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit.
Menge AC; Michalek SM; Russell MW; Mestecky J
Infect Immun; 1993 May; 61(5):2162-71. PubMed ID: 8478106
[TBL] [Abstract][Full Text] [Related]
5. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle.
Kozlowski PA; Williams SB; Lynch RM; Flanigan TP; Patterson RR; Cu-Uvin S; Neutra MR
J Immunol; 2002 Jul; 169(1):566-74. PubMed ID: 12077289
[TBL] [Abstract][Full Text] [Related]
6. Immunological tools for the assessment of both humoral and cellular immune responses in Foxes (Vulpes vulpes) using ovalbumin and cholera toxin B as an antigenic model.
Rolland-Turner M; Farre G; Muller D; Rouet N; Boue F
Vaccine; 2004 Oct; 22(31-32):4163-72. PubMed ID: 15474706
[TBL] [Abstract][Full Text] [Related]
7. Release from Th1-type immune tolerance in spleen and enhanced production of IL-5 in Peyer's patch by cholera toxin B induce the glomerular deposition of IgA.
Yamanaka T; Tamauchi H; Suzuki Y; Suzuki H; Horikoshi S; Terashima M; Iwabuchi K; Habu S; Okumura K; Tomino Y
Immunobiology; 2016 Apr; 221(4):577-85. PubMed ID: 26719095
[TBL] [Abstract][Full Text] [Related]
8. Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit.
Russell MW; Moldoveanu Z; White PL; Sibert GJ; Mestecky J; Michalek S M
Infect Immun; 1996 Apr; 64(4):1272-83. PubMed ID: 8606090
[TBL] [Abstract][Full Text] [Related]
9. Response to mucosal antigen challenge in IgA nephropathy.
Layward L; Allen AC; Hattersley JM; Harper SJ; Feehally J
Exp Nephrol; 1995; 3(5):300-7. PubMed ID: 7583052
[TBL] [Abstract][Full Text] [Related]
10. IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1.
Suzuki H; Moldoveanu Z; Hall S; Brown R; Julian BA; Wyatt RJ; Tomana M; Tomino Y; Novak J; Mestecky J
Contrib Nephrol; 2007; 157():129-33. PubMed ID: 17495450
[TBL] [Abstract][Full Text] [Related]
11. Decreased cytokine-induced IgA subclass production by CD40-ligated circulating B cells in primary IgA nephropathy.
de Fijter JW; van Nisselrooij NI; Schroeijers WE; Daha MR; van Es LA; van Kooten C
Nephrol Dial Transplant; 1998 Feb; 13(2):285-92. PubMed ID: 9509436
[TBL] [Abstract][Full Text] [Related]
12. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
Nyström-Asklin J; Adamsson J; Harandi AM
Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
[TBL] [Abstract][Full Text] [Related]
13. Systemic and mucosal IgA responses to systemic antigen challenge in IgA nephropathy.
Layward L; Finnemore AM; Allen AC; Harper SJ; Feehally J
Clin Immunol Immunopathol; 1993 Dec; 69(3):306-13. PubMed ID: 8242901
[TBL] [Abstract][Full Text] [Related]
14. The ovine nasal mucosa: an alternative tissue site for mucosal immunization.
Sedgmen BJ; Lofthouse SA; Meeusen EN
Methods; 2006 Feb; 38(2):112-6. PubMed ID: 16427306
[TBL] [Abstract][Full Text] [Related]
15. Immunopathogenesis of IgAN.
Barratt J; Smith AC; Molyneux K; Feehally J
Semin Immunopathol; 2007 Nov; 29(4):427-43. PubMed ID: 17851660
[TBL] [Abstract][Full Text] [Related]
16. Effects of parenteral keyhole limpet hemocyanin or cholera toxin on intestinal immune response to keyhole limpet hemocyanin.
Hamilton SR; Keren DF; Yardley JH; Brown G
Int Arch Allergy Appl Immunol; 1982; 68(3):242-6. PubMed ID: 7085119
[TBL] [Abstract][Full Text] [Related]
17. Humoral immunity against the proline-rich peptide epitope of the IgA1 hinge region in IgA nephropathy.
Kokubo T; Hashizume K; Iwase H; Arai K; Tanaka A; Toma K; Hotta K; Kobayashi Y
Nephrol Dial Transplant; 2000 Jan; 15(1):28-33. PubMed ID: 10607764
[TBL] [Abstract][Full Text] [Related]
18. In vivo antibody response to mucosal (NASAL) and subcutaneous stimulation of influenza virus in patients with IgA nephropathy.
Kashem A; Endoh M; Yano N; Yamauchi F; Nomoto Y; Sakai H
Tokai J Exp Clin Med; 1992 May; 17(1):23-8. PubMed ID: 1523689
[TBL] [Abstract][Full Text] [Related]
19. Humoral immune response to influenza vaccination in patients with primary immunoglobulin A nephropathy. An analysis of isotype distribution and size of the influenza-specific antibodies.
van den Wall Bake AW; Beyer WE; Evers-Schouten JH; Hermans J; Daha MR; Masurel N; van Es LA
J Clin Invest; 1989 Oct; 84(4):1070-5. PubMed ID: 2794045
[TBL] [Abstract][Full Text] [Related]
20. Cholera toxin B stimulates systemic neutralizing antibodies after intranasal co-immunization with measles virus.
Muller CP; Beauverger P; Schneider F; Jung G; Brons NH
J Gen Virol; 1995 Jun; 76 ( Pt 6)():1371-80. PubMed ID: 7782766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
